Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan-Ping Guo

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pathology, Research and Practice|March 25, 2019
Expression level and prospective mechanism of miRNA-99a-3p in head and neck squamous cell carcinoma based on miRNA-chip and miRNA-sequencing data in 1, 167 casesGan-Guan Wei, Wan-Ping Guo, Zheng-Yi Tang, et al.
Cancer Medicine|November 4, 2024
Whether Primary Bone-Only Oligometastatic Nasopharyngeal Carcinoma Patients Benefit From Radiotherapy to the Bones on the Basis of Palliative Chemotherapy Plus Locoregional Radiotherapy?-A Large-Cohort Retrospective StudyWan-Ping Guo, Guo-Dong Jia, Si-Yi Xie, et al.
British Journal of Cancer|March 31, 2026
Incorporating early cfEBV DNA clearance into clinical risk stratification to tailor induction chemotherapy cycles for locoregionally advanced nasopharyngeal carcinomaWan-Ping Guo, Xuan Yu, Zi-Jian Lu, et al.
Advances in Medical Sciences|October 15, 2020
Clinical significance of CCNE2 protein and mRNA expression in thyroid cancer tissuesCui-Zhen Liu, Wan-Ping Guo, Jin-Bo Peng, et al.
Cancer Medicine|August 11, 2023
The map of bone metastasis in nasopharyngeal carcinoma: A real-world studyDong-Hua Luo, Jia-Xin Li, Wan-Ping Guo, et al.
Nano Letters|March 13, 2020
Chiral Second-Harmonic Generation from Monolayer WS<sub>2</sub>/Aluminum Plasmonic Vortex MetalensWan-Ping Guo, Wei-Yun Liang, Chang-Wei Cheng, et al.
World Journal of Surgical Oncology|September 6, 2020
Immunohistochemical basigin expression level in thyroid cancer tissuesWan-Ping Guo, Deng Tang, Yu-Yan Pang, et al.
The Lancet Regional Health. Western Pacific|September 11, 2023
Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trialDong-Hua Luo, Xiao-Yun Li, Shan-Shan Guo, et al.
Nature Communications|October 10, 2025
Extracellular vesicles derived EBV tegument protein BRRF2 suppresses cGAS phase separation to promote anti-viral innate immune evasionZhu-Long Hu, Zi-Qian Li, Yu Wang, et al.
Eclinicalmedicine|November 17, 2025
Epstein-Barr virus DNA-guided chemoradiotherapy for patients with low-risk locoregionally advanced nasopharyngeal carcinoma: a secondary 5-year follow-up analysis of an open-label, randomised controlled, phase 2 non-inferiority trialYu-Chen Li, Xiao-Yun Li, Kai-Qi Lan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pathology, Research and Practice|March 25, 2019
Expression level and prospective mechanism of miRNA-99a-3p in head and neck squamous cell carcinoma based on miRNA-chip and miRNA-sequencing data in 1, 167 casesGan-Guan Wei, Wan-Ping Guo, Zheng-Yi Tang, et al.
Cancer Medicine|November 4, 2024
Whether Primary Bone-Only Oligometastatic Nasopharyngeal Carcinoma Patients Benefit From Radiotherapy to the Bones on the Basis of Palliative Chemotherapy Plus Locoregional Radiotherapy?-A Large-Cohort Retrospective StudyWan-Ping Guo, Guo-Dong Jia, Si-Yi Xie, et al.
British Journal of Cancer|March 31, 2026
Incorporating early cfEBV DNA clearance into clinical risk stratification to tailor induction chemotherapy cycles for locoregionally advanced nasopharyngeal carcinomaWan-Ping Guo, Xuan Yu, Zi-Jian Lu, et al.
Advances in Medical Sciences|October 15, 2020
Clinical significance of CCNE2 protein and mRNA expression in thyroid cancer tissuesCui-Zhen Liu, Wan-Ping Guo, Jin-Bo Peng, et al.
Cancer Medicine|August 11, 2023
The map of bone metastasis in nasopharyngeal carcinoma: A real-world studyDong-Hua Luo, Jia-Xin Li, Wan-Ping Guo, et al.
Nano Letters|March 13, 2020
Chiral Second-Harmonic Generation from Monolayer WS<sub>2</sub>/Aluminum Plasmonic Vortex MetalensWan-Ping Guo, Wei-Yun Liang, Chang-Wei Cheng, et al.
World Journal of Surgical Oncology|September 6, 2020
Immunohistochemical basigin expression level in thyroid cancer tissuesWan-Ping Guo, Deng Tang, Yu-Yan Pang, et al.
The Lancet Regional Health. Western Pacific|September 11, 2023
Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trialDong-Hua Luo, Xiao-Yun Li, Shan-Shan Guo, et al.
Nature Communications|October 10, 2025
Extracellular vesicles derived EBV tegument protein BRRF2 suppresses cGAS phase separation to promote anti-viral innate immune evasionZhu-Long Hu, Zi-Qian Li, Yu Wang, et al.
Eclinicalmedicine|November 17, 2025
Epstein-Barr virus DNA-guided chemoradiotherapy for patients with low-risk locoregionally advanced nasopharyngeal carcinoma: a secondary 5-year follow-up analysis of an open-label, randomised controlled, phase 2 non-inferiority trialYu-Chen Li, Xiao-Yun Li, Kai-Qi Lan, et al.
Pageof 1